Logo

Aarti Pharmalabs Share Price

Aarti Pharmalabs (INR)669.59.4   (1.4%)

Exchange ScripsBSE543748NSEAARTIPHARMISININE0LRU01027

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Aarti Pharmalabs Performance

Market performance
Open price666.3
High675.95
Volumes393235
Prev Close669.5
Low636.5
Closing date2025-01-10
Historical performance
1 Year High721.70
3 Year High721.70
5 Year High721.70
1 Year Low399.55
3 Year Low234.80
5 Year Low234.80

Aarti Pharmalabs Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
6092
Face Value
Face Value (₹)
5
P/E Ratio
P/E Ratio
27.97
Dividend Yield
Dividend Yield
0.09 %

Aarti Pharmalabs Investment Returns

1 Year
31.3%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Aarti Pharmalabs Technicals

IndicatorsValueSignal
5-DMA660.33Bullish
10-DMA672.83Bearish
20-DMA635.26Bullish
50-DMA638.32Bullish
100-DMA639.71Bullish
200-DMA601.76Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters4646464646
Foreign Investors11111
Domestic Investors4545454545
Public Investors185390188966204076215750226240
Government11111

Aarti Pharmalabs Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income492342---
Operating Profit390934442095---
Interest172211120---
Depreciation732625421---
Profit Before Tax300526081554---
Consolidated Net Profit216919351223---
Adjusted EPS24214890---

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital45345322
Total Reserves171151513213409---
Minority Interest------------
Total Non-Current Liabilities1307849728---
Total Liabilities2582122440203992
Capital Work in Progress7856221652---
Total Assets2582122440203992

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities21642501-437---
Cash Flow from Investing Activities-2146-1578-1387---
Cash Flow from Financing Activitie97-16352604---
Net Cash Inflow / Outflow115-712779---
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 27.97.
  • 3Y Stock Price CAGR of the stock is 132.3.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹3909 Million.
  • The company generated revenue of ₹18526 Million in the previous financial year.

Aarti Pharmalabs

669.59.4   (1.4%)

Investment Amount: ₹ 52475
Current Value: ₹ 66950
Performance: 27.6%
P/L: ₹ 14475
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Dr. Reddy's Lab

9.2

1354.4

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month